Connect Biopharma Holdings (CNTB) Intangibles (2020 - 2026)
Connect Biopharma Holdings (CNTB) posted Intangibles of $43000.0 for Q1 2026, down 4.44% sequentially from $45000.0 in Q4 2025, and down 14.0% YoY from $50000.0 in Q1 2025.
Connect Biopharma Holdings (CNTB) Intangibles (2020 - 2026) Analysis & Trends
Connect Biopharma Holdings has reported Intangibles for 7 years, with the latest figure at $43000.0 in Q1 2026.
- Quarterly Intangibles fell 14.0% year-over-year to $43000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $43000.0 (down 14.0% YoY) and the FY2025 annual result came in at $45000.0, down 15.09% from the prior year.
- Intangibles fell to $43000.0 in Q1 2026 per CNTB's latest filing, from $45000.0 in the prior quarter.
- Over five years, Intangibles peaked at $79000.0 in Q2 2022 and troughed at $43000.0 in Q1 2026.
- A 5-year average of $56287.4 and a median of $53000.0 in 2024 frame the typical range for Intangibles.
- The sharpest annual moves came in 2022 and 2023: Intangibles retreated 19.9% in 2022, then dropped 11.63% in 2023.
- Over 5 years, Intangibles stood at $70161.4 in 2022, then decreased by 11.63% to $62000.0 in 2023, then fell by 14.52% to $53000.0 in 2024, then dropped by 15.09% to $45000.0 in 2025, then retreated by 4.44% to $43000.0 in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $43000.0, $45000.0, and $47000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Connect Biopharma Holdings | 148.41 Mn | 148.41 Mn | - | 42,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 42,000.00 |
| Mar 31, 2026 | 43,000.00 |
| Dec 31, 2025 | 45,000.00 |
| Sep 30, 2025 | 47,000.00 |
| Jun 30, 2025 | 48,000.00 |
| Mar 31, 2025 | 50,000.00 |
| Dec 31, 2024 | 53,000.00 |
| Jun 30, 2024 | 57,000.00 |
| Dec 31, 2023 | 62,000.00 |
| Jun 30, 2023 | 65,000.00 |
| Dec 31, 2022 | 70,161.43 |
| Jun 30, 2022 | 79,000.00 |
| Dec 31, 2021 | 87,589.37 |
| Dec 31, 2020 | 51,605.51 |